Pulmonx Corp (LUNG)
6.05
-0.09
(-1.47%)
USD |
NASDAQ |
Jun 25, 16:00
6.05
0.00 (0.00%)
Pre-Market: 20:00
Pulmonx Cash from Financing (TTM): 1.544M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 1.544M |
December 31, 2023 | 21.40M |
September 30, 2023 | 21.45M |
June 30, 2023 | 21.78M |
March 31, 2023 | 21.82M |
December 31, 2022 | 2.419M |
September 30, 2022 | 2.502M |
Date | Value |
---|---|
June 30, 2022 | 2.596M |
March 31, 2022 | 5.758M |
December 31, 2021 | 4.456M |
September 30, 2021 | 204.07M |
June 30, 2021 | 205.43M |
March 31, 2021 | 233.54M |
December 31, 2020 | 234.83M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.544M
Minimum
Mar 2024
234.83M
Maximum
Dec 2020
70.26M
Average
21.42M
Median
Cash from Financing (TTM) Benchmarks
Cutera Inc | -0.416M |
Dynatronics Corp | 2.065M |
Stereotaxis Inc | 0.055M |
Electromed Inc | 0.149M |
Myomo Inc | 9.303M |